Studies from genomic consortiums such as TCGA have demonstrated that ccRCC tumors are characterized by prototypical mutations in some common genes such as VHL, PBRM1, BAP1, SETD2, and TSC1 among others (Atlas, 2013). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.